https://www.selleckchem.com/pr....oducts/ngi-1ml414.ht
70% vs 72.79%; P  0.001), higher mortality risk (1.78% vs 0.92%; P = 0.003), lower proportion of cured or completed treatment (82.81% vs 84.97%; P = 0.022), and longer time from onset to end-of-treatment. The probability of recurrence was higher in bacteriological positive cases than those in bacteriological negative cases (0.5% vs 0.4% at 20months; P  0.05). Based on patient's epidemiological characteristics and bacteriological type, it was necessary to actively enact measures to control their recurrent. Based on patient's e